Projects funded by the NCN

Nanobodies labeled with alpha emitters as potential radiopharmaceuticals in targeted radioimmunotherapy

Call: SONATA 5 , Panel: ST4

Principal investigator: dr Marek Pruszyński

Instytut Chemii i Techniki Jądrowej

Radiolabelled up-converting nanoparticles as theranostic agents for multimodal imaging and targeted therapy

Call: SONATINA 8 , Panel: ST5

Principal investigator: dr Karolina Kinga Zajdel

Narodowe Centrum Badań Jądrowych

New biopolymer-based radioisotope nanocarriers for melanoma theranostics, synthesized by radiation technique

Call: OPUS 25 , Panel: ST5

Principal investigator: prof. Piotr Krzysztof Ulański

Politechnika Łódzka, Wydział Chemiczny

Bioconjugates labeled with alpha- and beta-particle emitting radionuclides as potential radiopharmaceuticals in Targeted...

Call: SONATA BIS 9 , Panel: ST4

Principal investigator: dr hab. Marek Pruszyński

Instytut Chemii i Techniki Jądrowej

Radiolabelled peptidomimetic inhibitors of the VEGF/NRP-1 complex for imaging of pathological angiogenesis associated wi...

Call: OPUS 17 , Panel: NZ7

Principal investigator: prof. Aleksandra Misicka-Kęsik

Uniwersytet Warszawski

Multimodal gold nanoparticles as potential radiopharmaceuticals in targeted radionuclide therapy

Call: SONATA 14 , Panel: ST4

Principal investigator: dr Agnieszka Majkowska-Pilip

Instytut Chemii i Techniki Jądrowej

Radiopharmaceuticals based on neurokinin-1 receptor antagonists for the diagnosis and therapy of a brain tumour - gliobl...

Call: OPUS 13 , Panel: NZ7

Principal investigator: prof. Aleksandra Misicka-Kęsik

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk